The intraocular lens (iol) implants market size has grown strongly in recent years. It will grow from $5.03 billion in 2025 to $5.38 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to limited surgical options, low patient awareness, slow technological adoption, restricted insurance coverage, high cost of conventional lenses.
The intraocular lens (iol) implants market size is expected to see strong growth in the next few years. It will grow to $6.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rise in geriatric population, increase in cataract surgeries, advancements in lens technology, growing adoption of premium lenses, expansion of ophthalmology clinics. Major trends in the forecast period include minimally invasive surgical techniques, customized & premium iol implants, aging population & increased cataract prevalence, growth of outpatient ophthalmology clinics, advanced lens materials and coatings.
The rising number of cataract surgeries is expected to drive the growth of the intraocular lens (IOL) implants market in the coming years. Cataract surgery, which involves removing the eye’s cloudy lens and replacing it with an artificial intraocular lens to restore clear vision, is becoming more common due to the aging population, as older individuals are more susceptible to vision impairment requiring surgical intervention. IOL implants enhance these surgeries by replacing the clouded natural lens with a clear artificial one, restoring sharp vision, improving overall visual outcomes, reducing dependence on corrective eyewear, and enabling faster recovery with long-term visual stability. For instance, in April 2024, the Royal College of Ophthalmologists, a UK-based professional association, reported that cataract procedures in England increased to over 680,000 in 2023-24, up from the previous year, highlighting how the growing number of cataract surgeries is fueling the expansion of the IOL implants market.
Key players in the intraocular lens implants market are concentrating on developing next-generation presbyopia-correcting lenses to improve visual results and reduce patients’ reliance on glasses. These advanced lenses are designed to restore clear vision at various distances - near, intermediate, and far - for individuals with presbyopia. They help minimize or eliminate the need for reading glasses or bifocals after cataract surgery, offering greater visual independence and enhancing quality of life. For instance, in June 2025, Johnson & Johnson, a U.S.-based pharmaceutical company, introduced the Tecnis Odyssey, a next-generation intraocular lens that provides clear vision across all distances and lighting conditions. This lens uses advanced optics combined with a unique diffractive surface to deliver continuous, high-contrast vision while reducing night-time visual disturbances such as halos and glare. This innovation aims to give cataract patients improved visual freedom and a better quality of life.
In January 2023, Bausch + Lomb Corporation, a U.S.-based eye health company, acquired AcuFocus Inc. for an undisclosed amount. This acquisition was intended to broaden Bausch + Lomb’s intraocular lens portfolio by incorporating AcuFocus’s small-aperture technology, particularly the IC-8 Apthera IOL, designed to better address the needs of cataract patients with presbyopia and mild corneal astigmatism. AcuFocus Inc. is a U.S.-based medical device firm specializing in developing innovative ophthalmic technologies, including small-aperture intraocular lenses for the treatment of presbyopia and cataracts.
Major companies operating in the intraocular lens (iol) implants market are Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Appasamy Associates Private Limited, STAAR Surgical Company, Aurolab, Lenstec Inc., Rayner Intraocular Lenses Limited, Omni Lens Private Limited, Ophtec B.V., Hanita Lenses R.C.A Ltd., Shanghai Haohai Biological Technology Co. Ltd., Biotech Vision Care Pvt. Ltd., HumanOptics AG, Soleko S.p.A., Care Group Sight Solutions Private Limited, Cristalens Industrie SAS, SAV-IOL SA, Eyebright Medical Technology (Beijing) Co. Ltd., Eagle Optics Pvt. Ltd., SIFI S.p.A.
North America was the largest region in the intraocular lens (IOL) implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intraocular lens (iol) implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intraocular lens (iol) implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the intraocular lens (IOL) implants market by increasing the cost of imported lenses and surgical instruments, particularly affecting foldable and premium IOL segments. Regions such as North America and Europe, which rely heavily on imports from Asia-Pacific manufacturing hubs, face higher production costs and slower market growth. Hospitals and ambulatory surgical centers are most impacted due to tighter procurement budgets. However, tariffs have encouraged local manufacturing and innovation, allowing some companies to develop cost-efficient lenses and reduce dependence on imports, potentially creating new market opportunities.
The intraocular lens (iol) implants market research report is one of a series of new reports that provides intraocular lens (iol) implants market statistics, including intraocular lens (iol) implants industry global market size, regional shares, competitors with a intraocular lens (iol) implants market share, detailed intraocular lens (iol) implants market segments, market trends and opportunities, and any further data you may need to thrive in the intraocular lens (iol) implants industry. This intraocular lens (iol) implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intraocular lens (IOL) implants are artificial lenses surgically placed inside the eye to replace the natural lens, most commonly removed during cataract surgery. These implants help restore clear vision by focusing light directly onto the retina after the cloudy natural lens is extracted.
The primary types of intraocular lens implants include non-foldable and foldable lenses. Non-foldable lenses, typically made from polymethyl methacrylate (PMMA), are rigid and require larger incisions during surgery due to their inability to fold. IOLs are manufactured from a range of materials such as silicone, PMMA, hydrophilic acrylic, hydrophobic acrylic, and hybrid materials. These implants are used across various surgical techniques, including phacoemulsification, extracapsular cataract extraction (ECCE), small incision cataract surgery (SICS), and femtosecond laser-assisted procedures. Applications include cataract surgery, refractive surgery, presbyopia correction, and secondary IOL implantation. The main end users consist of hospitals, ambulatory surgical centers (ASCs), ophthalmology clinics, eye research institutes, and other healthcare settings.
The intraocular lens (IOL) implants market consists of sales of monofocal intraocular lenses, multifocal intraocular lenses, toric intraocular lenses, accommodative intraocular lenses, extended depth of focus (EDOF) intraocular lenses, and phakic intraocular lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The intraocular lens (iol) implants market size is expected to see strong growth in the next few years. It will grow to $6.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rise in geriatric population, increase in cataract surgeries, advancements in lens technology, growing adoption of premium lenses, expansion of ophthalmology clinics. Major trends in the forecast period include minimally invasive surgical techniques, customized & premium iol implants, aging population & increased cataract prevalence, growth of outpatient ophthalmology clinics, advanced lens materials and coatings.
The rising number of cataract surgeries is expected to drive the growth of the intraocular lens (IOL) implants market in the coming years. Cataract surgery, which involves removing the eye’s cloudy lens and replacing it with an artificial intraocular lens to restore clear vision, is becoming more common due to the aging population, as older individuals are more susceptible to vision impairment requiring surgical intervention. IOL implants enhance these surgeries by replacing the clouded natural lens with a clear artificial one, restoring sharp vision, improving overall visual outcomes, reducing dependence on corrective eyewear, and enabling faster recovery with long-term visual stability. For instance, in April 2024, the Royal College of Ophthalmologists, a UK-based professional association, reported that cataract procedures in England increased to over 680,000 in 2023-24, up from the previous year, highlighting how the growing number of cataract surgeries is fueling the expansion of the IOL implants market.
Key players in the intraocular lens implants market are concentrating on developing next-generation presbyopia-correcting lenses to improve visual results and reduce patients’ reliance on glasses. These advanced lenses are designed to restore clear vision at various distances - near, intermediate, and far - for individuals with presbyopia. They help minimize or eliminate the need for reading glasses or bifocals after cataract surgery, offering greater visual independence and enhancing quality of life. For instance, in June 2025, Johnson & Johnson, a U.S.-based pharmaceutical company, introduced the Tecnis Odyssey, a next-generation intraocular lens that provides clear vision across all distances and lighting conditions. This lens uses advanced optics combined with a unique diffractive surface to deliver continuous, high-contrast vision while reducing night-time visual disturbances such as halos and glare. This innovation aims to give cataract patients improved visual freedom and a better quality of life.
In January 2023, Bausch + Lomb Corporation, a U.S.-based eye health company, acquired AcuFocus Inc. for an undisclosed amount. This acquisition was intended to broaden Bausch + Lomb’s intraocular lens portfolio by incorporating AcuFocus’s small-aperture technology, particularly the IC-8 Apthera IOL, designed to better address the needs of cataract patients with presbyopia and mild corneal astigmatism. AcuFocus Inc. is a U.S.-based medical device firm specializing in developing innovative ophthalmic technologies, including small-aperture intraocular lenses for the treatment of presbyopia and cataracts.
Major companies operating in the intraocular lens (iol) implants market are Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Appasamy Associates Private Limited, STAAR Surgical Company, Aurolab, Lenstec Inc., Rayner Intraocular Lenses Limited, Omni Lens Private Limited, Ophtec B.V., Hanita Lenses R.C.A Ltd., Shanghai Haohai Biological Technology Co. Ltd., Biotech Vision Care Pvt. Ltd., HumanOptics AG, Soleko S.p.A., Care Group Sight Solutions Private Limited, Cristalens Industrie SAS, SAV-IOL SA, Eyebright Medical Technology (Beijing) Co. Ltd., Eagle Optics Pvt. Ltd., SIFI S.p.A.
North America was the largest region in the intraocular lens (IOL) implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intraocular lens (iol) implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intraocular lens (iol) implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the intraocular lens (IOL) implants market by increasing the cost of imported lenses and surgical instruments, particularly affecting foldable and premium IOL segments. Regions such as North America and Europe, which rely heavily on imports from Asia-Pacific manufacturing hubs, face higher production costs and slower market growth. Hospitals and ambulatory surgical centers are most impacted due to tighter procurement budgets. However, tariffs have encouraged local manufacturing and innovation, allowing some companies to develop cost-efficient lenses and reduce dependence on imports, potentially creating new market opportunities.
The intraocular lens (iol) implants market research report is one of a series of new reports that provides intraocular lens (iol) implants market statistics, including intraocular lens (iol) implants industry global market size, regional shares, competitors with a intraocular lens (iol) implants market share, detailed intraocular lens (iol) implants market segments, market trends and opportunities, and any further data you may need to thrive in the intraocular lens (iol) implants industry. This intraocular lens (iol) implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intraocular lens (IOL) implants are artificial lenses surgically placed inside the eye to replace the natural lens, most commonly removed during cataract surgery. These implants help restore clear vision by focusing light directly onto the retina after the cloudy natural lens is extracted.
The primary types of intraocular lens implants include non-foldable and foldable lenses. Non-foldable lenses, typically made from polymethyl methacrylate (PMMA), are rigid and require larger incisions during surgery due to their inability to fold. IOLs are manufactured from a range of materials such as silicone, PMMA, hydrophilic acrylic, hydrophobic acrylic, and hybrid materials. These implants are used across various surgical techniques, including phacoemulsification, extracapsular cataract extraction (ECCE), small incision cataract surgery (SICS), and femtosecond laser-assisted procedures. Applications include cataract surgery, refractive surgery, presbyopia correction, and secondary IOL implantation. The main end users consist of hospitals, ambulatory surgical centers (ASCs), ophthalmology clinics, eye research institutes, and other healthcare settings.
The intraocular lens (IOL) implants market consists of sales of monofocal intraocular lenses, multifocal intraocular lenses, toric intraocular lenses, accommodative intraocular lenses, extended depth of focus (EDOF) intraocular lenses, and phakic intraocular lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Intraocular Lens (IOL) Implants Market Characteristics
3. Intraocular Lens (IOL) Implants Market Supply Chain Analysis
4. Global Intraocular Lens (IOL) Implants Market Trends and Strategies
5. Intraocular Lens (IOL) Implants Market Analysis of End Use Industries
7. Global Intraocular Lens (IOL) Implants Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Intraocular Lens (IOL) Implants Total Addressable Market (TAM) Analysis for the Market
9. Intraocular Lens (IOL) Implants Market Segmentation
10. Intraocular Lens (IOL) Implants Market Regional and Country Analysis
11. Asia-Pacific Intraocular Lens (IOL) Implants Market
12. China Intraocular Lens (IOL) Implants Market
13. India Intraocular Lens (IOL) Implants Market
14. Japan Intraocular Lens (IOL) Implants Market
15. Australia Intraocular Lens (IOL) Implants Market
16. Indonesia Intraocular Lens (IOL) Implants Market
17. South Korea Intraocular Lens (IOL) Implants Market
18. Taiwan Intraocular Lens (IOL) Implants Market
19. South East Asia Intraocular Lens (IOL) Implants Market
20. Western Europe Intraocular Lens (IOL) Implants Market
21. UK Intraocular Lens (IOL) Implants Market
22. Germany Intraocular Lens (IOL) Implants Market
23. France Intraocular Lens (IOL) Implants Market
24. Italy Intraocular Lens (IOL) Implants Market
25. Spain Intraocular Lens (IOL) Implants Market
26. Eastern Europe Intraocular Lens (IOL) Implants Market
27. Russia Intraocular Lens (IOL) Implants Market
28. North America Intraocular Lens (IOL) Implants Market
29. USA Intraocular Lens (IOL) Implants Market
30. Canada Intraocular Lens (IOL) Implants Market
31. South America Intraocular Lens (IOL) Implants Market
32. Brazil Intraocular Lens (IOL) Implants Market
33. Middle East Intraocular Lens (IOL) Implants Market
34. Africa Intraocular Lens (IOL) Implants Market
36. Intraocular Lens (IOL) Implants Market Competitive Landscape and Company Profiles
37. Intraocular Lens (IOL) Implants Market Other Major and Innovative Companies
40. Intraocular Lens (IOL) Implants Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Intraocular Lens (IOL) Implants Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses intraocular lens (iol) implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intraocular lens (iol) implants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intraocular lens (iol) implants market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Non-Foldable Intraocular Lens (IOL) Implants; Foldable Intraocular Lens (IOL) Implants2) By Material Of Intraocular Lens (IOL): Silicone Intraocular Lens; Polymethyl Methacrylate (PMMA) Intraocular Lens; Hydrophilic Acrylic Intraocular Lens; Hydrophobic Acrylic Intraocular Lens; Combination Materials Intraocular Lens
3) By Surgical Technique: Phacoemulsification; Extracapsular Cataract Extraction (ECCE); Small Incision Cataract Surgery (SICS); Femtosecond Laser-Assisted Surgery
4) By Application: Cataract Surgery; Refractive Surgery; Presbyopia Correction; Secondary Intraocular Lens Implantation
5) By End User: Hospitals; Ambulatory Surgical Centers (ASCs); Ophthalmology Clinics; Eye Research Institutes; Other End Users
Subsegments:
1) By Non-Foldable Intraocular Lens (IOL) Implants: Rigid Polymethyl Methacrylate (PMMA) Intraocular Lenses; Anterior Chamber Intraocular Lenses; Posterior Chamber Intraocular Lenses2) By Foldable Intraocular Lens (IOL) Implants: Hydrophilic Acrylic Intraocular Lenses; Hydrophobic Acrylic Intraocular Lenses; Silicone Intraocular Lenses; Collamer Intraocular Lenses
Companies Mentioned: Bausch & Lomb Incorporated; Carl Zeiss Meditec AG; Appasamy Associates Private Limited; STAAR Surgical Company; Aurolab; Lenstec Inc.; Rayner Intraocular Lenses Limited; Omni Lens Private Limited; Ophtec B.V.; Hanita Lenses R.C.A Ltd.; Shanghai Haohai Biological Technology Co. Ltd.; Biotech Vision Care Pvt. Ltd.; HumanOptics AG; Soleko S.p.A.; Care Group Sight Solutions Private Limited; Cristalens Industrie SAS; SAV-IOL SA; Eyebright Medical Technology (Beijing) Co. Ltd.; Eagle Optics Pvt. Ltd.; SIFI S.p.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Intraocular Lens (IOL) Implants market report include:- Bausch & Lomb Incorporated
- Carl Zeiss Meditec AG
- Appasamy Associates Private Limited
- STAAR Surgical Company
- Aurolab
- Lenstec Inc.
- Rayner Intraocular Lenses Limited
- Omni Lens Private Limited
- Ophtec B.V.
- Hanita Lenses R.C.A Ltd.
- Shanghai Haohai Biological Technology Co. Ltd.
- Biotech Vision Care Pvt. Ltd.
- HumanOptics AG
- Soleko S.p.A.
- Care Group Sight Solutions Private Limited
- Cristalens Industrie SAS
- SAV-IOL SA
- Eyebright Medical Technology (Beijing) Co. Ltd.
- Eagle Optics Pvt. Ltd.
- SIFI S.p.A.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.38 Billion |
| Forecasted Market Value ( USD | $ 6.93 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
